Shenzhen Yifeng Investment Management Enterprise

Venture capital · Shenzhen, Guangdong

Shenzhen Yifeng Investment Management Enterprise is a venture capital firm based in Shenzhen, Guangdong. Founded in 2007, Efung Capital is a venture capital firm based in Shenzhen, China. 36 portfolio companies are on record.

AUM
—
Portfolio companies
36
Recorded deals
130
12 in last 12M
Last investment
—

Shenzhen Yifeng Investment Management Enterprise key facts

  • Shenzhen Yifeng Investment Management Enterprise is a venture capital firm based in Shenzhen, Guangdong with 36 tracked portfolio companies.
  • Notable positions include MingMed Biotech, Trinomab(Zhuhai), Hexin Medical.

About Shenzhen Yifeng Investment Management Enterprise

Founded in 2007, Efung Capital is a venture capital firm based in Shenzhen, China. The firm seeks to invest in the healthcare and life science sectors.

Shenzhen Yifeng Investment Management Enterprise portfolio at a glance

36 portfolio companies are on record for Shenzhen Yifeng Investment Management Enterprise, including MingMed Biotech, Trinomab(Zhuhai) and Hexin Medical.

13 of the 36 carry a recorded valuation.

Is this your firm? Sign in with your work email to keep it current, or tell us what's wrong.

Free account
See more of the book
  • ·The top 10 names in the book — of 36 recorded positions
  • ·Watchlist + alerts for Shenzhen Yifeng Investment Management Enterprise's activity
Create free account

Membership and data by Private Market View

No card required

Portfolio

36 companies · priced for members
CompanyValuationRole
MingMed Biotech▮▮
Trinomab(Zhuhai)▮▮
Hexin Medical▮▮
+ 33 more companies · all 36, priced and dated
or a free account shows the top 10 names — no card
The whole book · Pro $99 a month

Membership and data by Private Market View

Frequently asked about Shenzhen Yifeng Investment Management Enterprise

What companies does Shenzhen Yifeng Investment Management Enterprise invest in?
Shenzhen Yifeng Investment Management Enterprise has 36 recorded portfolio companies, including MingMed Biotech, Trinomab(Zhuhai), Hexin Medical.